Implied Volatility MoversHuman Genome Sciences (HGSI) implied volatility is moving higher, as players in the options market are bracing for the Food and Drug Administration [FDA] final decision on Benlysta. The FDA is expected to decide whether or not to approve the Lupus drug around March 10. Shares are down 18 cents to $25.56 and today's volume includes 17,000 calls, 27,000 puts. March 15 and 20 puts are the most actives and implied volatility is moving up 6 percent to 90, up 14 percent on the week.
Unusual Volume Sprint Nextel (S) options volume is running 2X the (22-day) average, with 77,000 contracts traded and call volume accounting for 93 percent of the volume.
TIVO options volume is 3X the average daily, with 67,000 contracts traded and call volume representing for 71 percent of the activity.
H&R Block (HRB) options volume is running 4X the average daily, with 28,000 contracts traded and call volume accounting for 87 percent of the activity.
Increasing options activity is also being seen in
BHP.
Human Genome Sciences (HGSI), and
Radioshack (RSH).
